Gilead Sciences (NQ: GILD)
75.29 USD  +2.43 (+3.34%)
Streaming Delayed Price  /  Updated: 12:40 PM EDT, Apr 23, 2014  /  Add to My Watchlist      
(GILD) Community Analysis from
April 23, 2014
(Jutia Group, 4/22/14)
[Business Wire] - Gilead Sciences, Inc. announced today its results of operations for the quarter ended March 31, 2014. Total...(read more)
(Jutia Group, 4/21/14)
[Business Wire] - Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has...(read more)
(Stock Blog Hub, 12/14/13)
One of the big winners of Obamacare will be the pharmaceutical industry. Despite new highs for most big pharma companies – they are currently sitting at prices we haven’t seen in a decade –...(read more)
Gilead Sciences (GILD) Company Overview

Gilead Sciences (NYSE: GILD) is a biopharmaceutical company that specializes in the development and commercialization of drugs for the treatment of HIV infection, hepatitis B infection (HBV), cystic fibrosis, fungal infections, and influenza A and B. The company currently produces a market-leading HIV drug portfolio as well as other drugs, which face strong competition from drug-makers such as GlaxoSmithKline (GSK), Novartis AG (NVS), Merck (MRK), Enzon Pharmaceuticals (ENZN), and Bristol-Myers Squibb Company (BMY).In 2010, Gilead generated $7.95 billion in revenues and net earnings of $2.9 billion.[1]

Gilead's profitability can be potentially affected by various factors, including legislative and regulatory changes in federal and private insurance coverage of its drug products, competition from the development of generic drug substitutes, supply shortages of active ingredients in its drugs, the success of clinical trials of newly-developed drugs, and changes in FDA regulations.

(Read more at Wikinvest )

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

Gilead Sciences (GILD) Stock Price Quotes

Stock price quotes and latest news for Gilead Sciences. Stock data and related company industries for Gilead Sciences. Find company charts, news, SEC Filings, and historical stock prices and stock quotes for Gilead Sciences. Compare Gilead Sciences (GILD) stock, pricing by 5 day incremental time frames. Gilead Sciences Stock Price Quotes include strike price, current price, price change percentage, and volume. Join Stocknod for stock trading signalsand stock trading softwarefor superior stock market timing.

Gilead Sciences Real-Time Stock Quotes

Real-time stock quotes for Gilead Sciences include GILD news, GILD Blogs, and GILD Podcasts. Get all of your up to the minute press release coverage for Gilead Sciences. Stay up to date with conference calls, board meeting news, and latest press releases with Gilead Sciences (GM) Stock Price Quotes.